Menu
  • Active Trials
    • Actinic Keratosis
    • Alopecia Areata
    • Atopic Dermatitis
    • Bullous Pemphigoid
    • Hydradenitis Suppurativa
    • Prurigo Nodularis
    • Psoriasis
    • Rosacea
    • Skin Cancer
    • Skincare
    • Vitiligo
  • Solutions
    • Patients
    • Sponsors
  • About
  • Locations
  • Contact

atopic dermatitis
Clinical Trials

Atopic Dermatitis (ROCKET-SHUTTLE Study)

A study to evaluate the efficacy of rocatinlimab in combination with topical corticosteroid compared with a placebo for Atopic Dermatitis.

Trial available at the following locations:
Texas, 
View Trial

Atopic Dermatitis (ROCKET-Horizon Study)

This study evaluates the efficacy of rocatinlimab compared with a placebo assessed using Validated Investigator’s Global Assessment for patients with Atopic Dermatitis.

Trial available at the following locations:
Texas,  Kansas, 
View Trial

Atopic Dermatitis (ROCKET-ASTRO Study)

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subjects with Atopic Dermatitis.

Trial available at the following locations:
Texas, 
View Trial

Atopic Dermatitis (DISCOVER Study)

The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis with the aim to test the safety and effectiveness of the study drug.

Trial available at the following locations:
Maryland, 
View Trial
Atopic dermatitis

Atopic Dermatitis (NEURADAD Study)

A study to quantify deficits in cognitive functioning in adolescents with moderate-to-severe Atopic Dermatitis, using the Conners’ Continuous Performance Test 3rd Edition.

Trial available at the following locations:
Maryland, 
View Trial

Atopic Dermatitis (Difamilast Study)

A study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate Atopic Dermatitis.

Trial available at the following locations:
Maryland, 
View Trial
Atopic Dermatitis Clinical Trial in Texas

Atopic Dermatitis (Eli Lilly and Company Study)

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.

Trial available at the following locations:
Arizona, 
View Trial
Atopic DERM

Atopic Dermatitis (Q32 Bio Inc. Study)

A randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.

Trial available at the following locations:
Maryland, 
View Trial

Atopic Dermatitis (Corrona-AD-550 Study)

A study on comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis.

Trial available at the following locations:
Kansas,  Missouri,  Texas,  Arizona, 
View Trial
Atopic Dermatitis

Atopic Dermatitis (Eli Lilly Study)

A clinical trial to evaluate lebrikizumab in adult participants with moderate-to-severe Atopic Dermatitis previously treated with Dupilumab.

Trial available at the following locations:
Arizona, 
View Trial

Atopic Dermatitis (ROCKET-Ignite Study)

A clinical trial to evaluate rocatinlimab in monotherapy treatment with moderate-to-severe Atopic Dermatitis in adults.

Trial available at the following locations:
Arizona,  Texas,  Kansas, 
View Trial
Atopic Dermatitis

Atopic Dermatitis (ROCKET-Orbit Study)

A clinical trial to study the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe Atopic Dermatitis

Trial available at the following locations:
Maryland,  Texas, 
View Trial
A clinical trial to evaluate oral upadacitinib to subcutaneous dupilumab with moderate-to-severe Atopic Dermatitis in adults & adolescents.

Atopic Dermatitis (Level Up Study)

A clinical trial to evaluate oral upadacitinib to subcutaneous dupilumab with moderate-to-severe Atopic Dermatitis in adults & adolescents.

Trial available at the following locations:
Arizona, 
View Trial
Atopic Dermatitis

Atopic Dermatitis (Dupilumab Study)

A clinical trial to assess the long-term safety of Dupilumab administered in Participants ≥6 Months to 18 years of age with Atopic Dermatitis.

Trial available at the following locations:
Maryland, 
View Trial
Atopic dermatitis

Atopic Dermatitis (TARGET-DERM Study)

A clinical trial of a longitudinal observational study of patients undergoing therapy for IMISC (TARGET-DERM).

Trial available at the following locations:
Maryland, 
View Trial

Atopic Dermatitis (DermTech Patch)

A prospective sample collection study using non-invasive methods to investigate biomarkers in Atopic Dermatitis patients

Trial available at the following locations:
Arizona, 
View Trial

Seborrheic Dermatitis (STRATUM Study)

A clinical trial of PDE4 inhibition with roflumilast for the management of Seborrheic Dermatitis (STRATUM Study).

Trial available at the following locations:
Maryland, 
View Trial

Atopic Dermatitis (Corrona Registry)

Corrona Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

Trial available at the following locations:
Arizona,  Kansas,  Maryland,  Missouri,  Texas, 
View Trial

ACTIVE TRIALS

  • Actinic Keratosis
  • Atopic Dermatitis
  • Bullous Pemphigoid
  • Hidradenitis Suppurativa
  • Prurigo Nodularis
  • Psoriasis
  • Skin Cancer

LOCATIONS

  • Arizona
  • Kansas
  • Missouri
  • Maryland
  • Texas

NAVIGATION

  • Active Trials
  • About
  • Locations
  • Contact

SOLUTIONS

  • Patients
  • Providers

PRIVACY POLICY | TERMS OF USE

Input your search keywords and press Enter.